IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Lanxess Posts Huge Hike in Profits; Raises Earnings Forecast; Scales Back Cost-Cutting Plans

10:36 AM MDT | August 6, 2010 | Natasha Alperowicz

Lanxess beat market expectations for the second quarter as a result of a strong performance in emerging markets, reporting Ebitda pre-exceptionals of €269 million ($354 million) compared to €112 million in the year-earlier period. Sales were up 48% at €1.83 billion and net profit soared to €131 million from €17 million in the second quarter of 2009. The company has raised its earnings forecast for 2010 and now expects Ebitda pre-exceptionals of "roughly €800 million," compared with forecasts made in May of €650 million...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa